Literature DB >> 20227738

Differentiation of Leishmania (Viannia) panamensis and Leishmania (V.) guyanensis using BccI for hsp70 PCR-RFLP.

Ana Margarita Montalvo Alvarez1, Jorge Fraga Nodarse, Ivón Montano Goodridge, Lianet Monzote Fidalgo, Marcel Marin, Gert Van Der Auwera, Jean-Claude Dujardin, Iván Darío Velez Bernal, Carlos Muskus.   

Abstract

Leishmania panamensis and Leishmania guyanensis are two species of the subgenus Viannia that are genetically very similar. Both parasites are usually associated with cutaneous leishmaniasis, but also have the potential to cause the mucocutaneous form of the disease. In addition, the study of foci and consequently the identification of vectors and probable reservoirs involved in transmission require a correct differentiation between both species, which is important at epidemiological level. We explored the possibility of identifying these species by using restriction fragment length polymorphisms (RFLP) in the gene coding for heat-shock protein 70 (hsp70). Previously, an hsp70 PCR-RFLP assay proved to be very effective in differentiating other Leishmania species when HaeIII is used as restriction enzyme. Based on hsp70 sequences analysis, BccI was found to generate species-specific fragments that can easily be recognized by agarose gel electrophoresis. Using the analysis of biopsies, scrapings, and parasite isolates previously grouped in a cluster comprising both L. panamensis and L. guyanensis, we showed that our approach allowed differentiation of both entities. This offers the possibility not only for identification of parasites in biological samples, but also to apply molecular epidemiology in certain countries of the New World, where several Leishmania species could coexist. Copyright 2009 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20227738     DOI: 10.1016/j.trstmh.2009.12.002

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  10 in total

1.  Leishmania (Viannia) shawi purified antigens confer protection against murine cutaneous leishmaniasis.

Authors:  Luiz Felipe Domingues Passero; Ana Kely Carvalho; Maria Luiza A C Bordon; Alexis Bonfim-Melo; Marcos Hikari Toyama; Carlos Eduardo Pereira Corbett; Márcia Dalastra Laurenti
Journal:  Inflamm Res       Date:  2011-12-14       Impact factor: 4.575

2.  Three new sensitive and specific heat-shock protein 70 PCRs for global Leishmania species identification.

Authors:  A M Montalvo; J Fraga; I Maes; J-C Dujardin; G Van der Auwera
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-15       Impact factor: 3.267

3.  Imported cases of cutaneous leishmaniasis in Cuba, 2017: role of human movement.

Authors:  Lianet Monzote; Daniel González; Orestes Blanco; Jorge Fraga; Virginia Capó; Alberto Herrera; Ana Margarita Montalvo
Journal:  Trop Dis Travel Med Vaccines       Date:  2022-07-01

4.  Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasis.

Authors:  Liliana López; Martha Robayo; Margarita Vargas; Iván D Vélez
Journal:  Trials       Date:  2012-05-17       Impact factor: 2.279

5.  Easy identification of leishmania species by mass spectrometry.

Authors:  Oussama Mouri; Gloriat Morizot; Gert Van der Auwera; Christophe Ravel; Marie Passet; Nathalie Chartrel; Isabelle Joly; Marc Thellier; Stéphane Jauréguiberry; Eric Caumes; Dominique Mazier; Carine Marinach-Patrice; Pierre Buffet
Journal:  PLoS Negl Trop Dis       Date:  2014-06-05

6.  Evaluating the spatial distribution of Leishmania parasites in Colombia from clinical samples and human isolates (1999 to 2016).

Authors:  Clemencia Ovalle-Bracho; Diana Londoño-Barbosa; Jussep Salgado-Almario; Camila González
Journal:  PLoS One       Date:  2019-03-27       Impact factor: 3.240

7.  Molecular identification of two newly identified human pathogens causing leishmaniasis using PCR-based methods on the 3' untranslated region of the heat shock protein 70 (type I) gene.

Authors:  Narissara Jariyapan; Michelle D Bates; Paul A Bates
Journal:  PLoS Negl Trop Dis       Date:  2021-11-30

8.  Histopathological characteristics of cutaneous lesions caused by Leishmania Viannia panamensis in Panama.

Authors:  Kadir González; Rosendo Diaz; Aurea F Ferreira; Víctor García; Héctor Paz; José E Calzada; Michelle Ruíz; Márcia Laurenti; Azael Saldaña
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2018-02-15       Impact factor: 1.846

9.  PCR-RFLP analyses of Leishmania species causing cutaneous and mucocutaneous leishmaniasis revealed distribution of genetically complex strains with hybrid and mito-nuclear discordance in Ecuador.

Authors:  Hirotomo Kato; Eduardo A Gomez; Chisato Seki; Hayato Furumoto; Luiggi Martini-Robles; Jenny Muzzio; Manuel Calvopiña; Lenin Velez; Makoto Kubo; Ahmed Tabbabi; Daisuke S Yamamoto; Yoshihisa Hashiguchi
Journal:  PLoS Negl Trop Dis       Date:  2019-05-06

10.  Involvement of the Inflammasome and Th17 Cells in Skin Lesions of Human Cutaneous Leishmaniasis Caused by Leishmania (Viannia) panamensis.

Authors:  K Gonzalez; J E Calzada; C E P Corbett; A Saldaña; M D Laurenti
Journal:  Mediators Inflamm       Date:  2020-10-27       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.